New imaging test gives physicians better tool to diagnose Parkinson's disease

Physicians now have an objective test to evaluate patients for Parkinsonian syndromes, such as Parkinson's disease. DaTscan™ is the only FDA-approved imaging agent for assessment of movement disorders. Until now, there were no definitive tests to identify the disease, forcing physicians to rely on clinical examinations to make a diagnosis. This technology allows doctors to differentiate Parkinson's from other movement disorders.

Read the whole article on Science Daily

More from Science Daily